Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(21/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(21/week)
News
United States
(584/week)
Manufacturing
(403/week)
Energy
(324/week)
Technology
(409/week)
Other Manufacturing
(343/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Rigel Pharmaceuticals, Inc.
Jan 29, 2021
Rigel Awarded $16.5 Million from U.S. Department of Defense for Phase 3 Clinical Trial of Fostamatinib in COVID-19 Patients
Jan 11, 2021
Rigel Pharmaceuticals Provides Business Update
Jan 07, 2021
Rigel to Present at the 39th Annual J.P. Morgan Healthcare Conference
Dec 04, 2020
Rigel Announces Two Posters Highlighting TAVALISSE at the 62nd ASH Annual Meeting & Exposition
Nov 23, 2020
Rigel and Medison Announce Health Canada Approval of TAVALISSE®, an Oral Medication for the Treatment of Adults with Chronic Immune Thrombocytopenia
Nov 17, 2020
Rigel Finalizes the Study Design of its Ongoing Phase 3 Clinical Trial of Fostamatinib in Warm Autoimmune Hemolytic Anemia
Nov 10, 2020
Rigel to Present at the Jefferies Virtual London Healthcare Conference
Nov 05, 2020
Rigel Reports Third Quarter 2020 Financial Results and Provides Business Update
Oct 29, 2020
Rigel Announces Conference Call and Webcast to Report Third Quarter 2020 Financial Results and Business Update
Oct 09, 2020
Rigel Announces First Patients Enrolled in NIH/NHLBI-Sponsored Trial of Fostamatinib in Hospitalized COVID-19 Patients in Collaboration with Inova
Sep 17, 2020
Rigel Announces NIH/NHLBI-Sponsored Trial of Fostamatinib in Hospitalized COVID-19 Patients in Collaboration with Inova
Sep 09, 2020
Rigel to Present at Two Upcoming Investor Conferences
Sep 02, 2020
Rigel to Participate in Citi's 15th Annual BioPharma Virtual Conference
Aug 04, 2020
Rigel Reports Second Quarter 2020 Financial Results, Provides Business Update, and Overviews COVID-19 Program
Jul 27, 2020
Rigel Announces Post-hoc Data Analysis of TAVALISSE® in Adult Patients with Immune Thrombocytopenia Published in the British Journal of Haematology
Jul 09, 2020
Rigel Announces Availability of TAVLESSE® (Fostamatinib Disodium Hexahydrate) in Europe
Jun 17, 2020
Rigel to Present at the BMO 2020 Prescriptions for Success Healthcare Virtual Conference
Jun 11, 2020
Rigel to Present Poster Highlighting TAVALISSE at the Virtual Edition of the 25th European Hematology Association (EHA) Annual Congress
Jun 03, 2020
Rigel to Present Four Posters Highlighting IRAK1/4 Inhibitor at the EULAR 2020 E-Congress
May 05, 2020
Rigel Reports First Quarter 2020 Financial Results and Provides Business Update
Page 1
››
Latest News
May 12, 2024
Ørsted and Shipbuilder Edison Chouest Christen First-Ever American-Built, Offshore Wind Service Operations...
May 11, 2024
Pembina Pipeline Corporation Reports Voting Results from 2024 Annual Meeting of Shareholders
May 11, 2024
Terran Orbital Schedules Conference Call to Discuss First Quarter 2024 Financial Results
May 11, 2024
Fonon Corporation Highlights Applications for Its Laser Cutting Technology in the Mining Industry
May 11, 2024
Sky Harbour to Report 2024 Q1 Results and Host Webcast Investor Call Tuesday, May 14, 2024
May 11, 2024
Russia claims more advances after Ukraine ground offensive
May 11, 2024
La Corée du Nord va déployer un nouveau lance-roquettes multiple en 2024
May 11, 2024
SpinLaunch Board Announces Leadership Transition
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events